[HTML][HTML] Targeted therapy for hepatocellular carcinoma

A Huang, XR Yang, WY Chung, AR Dennison… - Signal transduction and …, 2020 - nature.com
The last 3 years have seen the emergence of promising targeted therapies for the treatment
of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a …

Targeted therapy for hepatocellular carcinoma.

A Huang, XR Yang, WY Chung… - … and Targeted Therapy, 2020 - europepmc.org
The last 3 years have seen the emergence of promising targeted therapies for the treatment
of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a …

[HTML][HTML] Targeted therapy for hepatocellular carcinoma

A Huang, XR Yang, WY Chung… - Signal Transduction …, 2020 - ncbi.nlm.nih.gov
The last 3 years have seen the emergence of promising targeted therapies for the treatment
of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a …

Targeted therapy for hepatocellular carcinoma

A Huang, XR Yang, WY Chung… - Signal transduction …, 2020 - pubmed.ncbi.nlm.nih.gov
The last 3 years have seen the emergence of promising targeted therapies for the treatment
of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a …

Targeted therapy for hepatocellular carcinoma

A Huang, XR Yang, WY Chung, AR Dennison… - Signal Transduction and …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The last 3 years have seen the emergence of
promising targeted therapies for the treatment of hepatocellular carcinoma (HCC). Sorafenib …

[HTML][HTML] Targeted therapy for hepatocellular carcinoma

H Ao, Y Xin-Rong, C Wen-Yuan… - Signal Transduction …, 2020 - search.proquest.com
The last 3 years have seen the emergence of promising targeted therapies for the treatment
of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a …

Targeted therapy for hepatocellular carcinoma.

A Huang, XR Yang, WY Chung… - … & Targeted Therapy, 2020 - search.ebscohost.com
The last 3 years have seen the emergence of promising targeted therapies for the treatment
of hepatocellular carcinoma (HCC). Sorafenib has been the mainstay of treatment for a …